• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Solution of early immune-response and development of new strategies of antibody-mediated rejection in kidney transplantation.

Research Project

Project/Area Number 26462464
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Urology
Research InstitutionTokyo Women's Medical University

Principal Investigator

Omoto Kazuya  東京女子医科大学, 医学部, 准講師 (90343558)

Co-Investigator(Kenkyū-buntansha) 土岐 大介  東京女子医科大学, 医学部, 助教 (60568591)
Co-Investigator(Renkei-kenkyūsha) ABE Ryo  東京理科大学, 生命科学研究所, 教授 (20159453)
Research Collaborator SAWADA Yugo  
HIRAI Toshihito  
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywords腎移植 / 抗体関連型拒絶 / 感作 / 抗ドナー抗体 / 調節性T細胞 / BAFF / 免疫グロブリン
Outline of Final Research Achievements

Intravenous immunoglobulin (IVIG) has evolved widespread use for treatment of antibody-mediated rejection (AMR). In order to investigate the mechanisms of IVIG and sequential fluctuation of donor-specific antibodies (DSA) titer, we administered high dose IVIG to sensitized recipient rats and measured the DSA-IgG levels sequentially. The levels of DSA-IgG in sensitized rats though IVIG gradually decreased. Then we could evaluate sequential pathological findings related to IVIG. Graft survival in IVIG group was significantly longer than that in PS group, but not in nonsensitized group. Additionally, BAFF serum levels successfully decreased, and significant in vivo increasing of proportion of regulatory T cells were observed in IVIG group. Thus, IVIG monotherapy can suppress the production of DSA-IgG and progress of AMR. However, it is insufficient to obtain complete desensitization, so that combination therapies which are targeting to various memory cells might be required.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (1 results)

All 2016

All Presentation (1 results) (of which Int'l Joint Research: 1 results)

  • [Presentation] Sequential analysis of donor-specific antibodies and pathological findings using intravenous immunoglobulin in a highly sensitized rat kidney transplant model.2016

    • Author(s)
      Yugo Sawada, Kazuya Omoto, Naoki Kohei, Kunio Kawanishi, Masayoshi Okumi, Ishida Hideki, and Kazunari Tanabe
    • Organizer
      2016 American Transplant Congress
    • Place of Presentation
      ボストン(米国)
    • Year and Date
      2016-06-11
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi